 NEW YORK , Nov. 16, 2020 GLOBE NEWSWIRE -- Silo Pharma, Inc. OTCQB: SILO today announced that its Board of Directors has named scientific research investigator Dr. Joshua Woolley, M.D. Ph.D. to its newly formed Scientific Advisory Board. 